Global Pharma and Healthcare Social Media Market Overview:
Pharma and healthcare social media can be used for connecting the customers, physicians, patients, and other professionals online. It is basically used for building its brand presence and increase its reach by conveying proper, accurate, and balanced information. Social media like Facebook, LinkedIn, Youtube, Instagram, and other such platforms are used. The pharma and healthcare companies mainly use branches of marketing for their promotion and customer engagement. Some of the players profiled in the study are AstraZeneca plc (United Kingdom), Sermo (United States), Doximity (United States), Abbott Healthcare (United States), Merck KGaA (Germany), unmetric (United States), Pfizer Inc. (United States), AbbVie Inc. (United States) and GlaxoSmithKline plc. (United Kingdom).
On the basis of geography, the market of Pharma and Healthcare Social Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Social Media, the sub-segment i.e. Facebook will boost the Pharma and Healthcare Social Media market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Growing Demand for Online Presence of Companies for Brand Awareness and Global Reach
- Digital Transformation in a Way of Socializing and Communication
- The popularity of Various Social Media Channels Among the Popular Healthcare and Pharma Companies
- Stringent Regulatory Compliances Associated with the Pharma and Healthcare Social Media
- Growing Young Population in Social Media Platform will Boost the Pharma and Healthcare Social Media Market
- Increasing Number of Digital Marketing Companies Across the World Serving Different Sectors
- Number of Local Pharma and Healthcare Companies Present in Social Media Market
"The Internet and various social media platforms have increasingly enabled drug and device manufacturers to more actively engage with consumers and healthcare providers. FDA held a Part 15 public hearing to gather comments and questions from our stakeholders (e.g., industry, health care providers, consumers, patient groups, Internet vendors, advertising agencies, and other interested parties) on how the FDA can best provide guidance on the promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools."
Target Audience:Pharma and Healthcare Social Media Page Developer, Pharma and Healthcare Social Media Industry Association, Pharma and Healthcare Organisations, Regulatory Bodies, Research and Development Institutes, Potential Investors and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Pharma and Healthcare Social Media market on the basis of product  , application [Hospitals, Clinics, Pharmaceutical and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Pharma and Healthcare Social Media market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Pharma and Healthcare Social Media industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Pharma and Healthcare Social Media market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.